The ARIA-EAACI 2024–2025 guidelines are an updated, evidence-based framework for the management of allergic rhinitis and its impact on asthma. They include recommendations on intranasal, oral, and ocular treatments, along with a detailed methodology paper describing the use of GRADE evidence-to-decision frameworks and digital shared decision-making tools. Developed by an international expert panel, these guidelines integrate clinical evidence, patient-centered outcomes, and digital health approaches to support improved diagnosis and treatment strategies worldwide.